Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
92.2M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
68.6M
-
Shares change
-
-2.79M
-
Total reported value, excl. options
-
$45M
-
Value change
-
-$1.72M
-
Number of buys
-
13
-
Number of sells
-
-16
-
Price
-
$0.66
Significant Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) as of Q2 2025
46 filings reported holding CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q2 2025.
Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.6M shares
of 92.2M outstanding shares and own 74.44% of the company stock.
Largest 10 shareholders include MPM BIOIMPACT LLC (14.7M shares), Avidity Partners Management LP (7.48M shares), Nextech Invest, Ltd. (7.42M shares), Deep Track Capital, LP (7.42M shares), Blue Owl Capital Holdings LP (7.41M shares), GREAT POINT PARTNERS LLC (4.68M shares), FRANKLIN RESOURCES INC (4M shares), VANGUARD GROUP INC (3.36M shares), Blackstone Inc. (2.44M shares), and Nantahala Capital Management, LLC (1.94M shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.